RE: SCANCELL14 Feb 2021 09:26
Morning Bojo.
Thanks for the heads up.
Just had a quick bit of research. My initial thoughts were perhaps the y have missed the boat but then you consider it further and I am not so sure.
So they are looking to produce something similar to the Novavax vaccine.
With all the information/research out there they will have a head start in terms of the development. Trials/phases I assume will have some priority.
So potentially they could have a drug approved in 12 to 18 months - any thoughts on this timescale?
Out of the vaccines out there, Pfizer's will be over run by the more user friendly vaccines , Modernas if very expensive, Novavax is circa £11.
So if Scanncell get a vaccine to the market at a reasonable cost it could very well find strong demand for it
I think if the time scale to produce a vaccine is reasonable this could be a very good share to add